Santen Pharmaceutical Co., Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of SNPHF for the last quarter is 545.89 M USD, and it's 11.11% higher compared to the previous quarter. The net income of Q3 23 is 51.93 M USD.